Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)

Project: Research

Short title	Sodium selanate in patients with bvFTD
Status	Active
Effective start/end date	1/04/19 → 31/03/25

A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia
Vivash, L., Malpas, C. B., Meletis, C., Gollant, M., Eratne, D., Lin, Q-X., McDonald, S., O'Brien, W. T., Brodtmann, A. G., Darby, D. G., Kyndt, C., Walterfang, M., Hovens, C. M., Velakoulis, D. & O'Brien, T. J., 2022, In: Alzheimer's & Dementia: Translational Research & Clinical Interventions. 8, 1, 9 p., e12299.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

2 Citations (Scopus)
Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia
Moses, J., Sinclair, B., Schwartz, D. L., Silbert, L. C., O’Brien, T. J., Law, M. & Vivash, L., 20 Oct 2022, In: Frontiers in Neuroscience. 16, 14 p., 1003522.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
Sodium selenate as a therapeutic for tauopathies: A hypothesis paper
Dilcher, R., Malpas, C. B., Walterfang, M., Velakoulis, D., O’Brien, T. J. & Vivash, L., 5 Aug 2022, In: Frontiers in Aging Neuroscience. 14, 12 p., 915460.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

Project Details